Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

freddyaophelps 453 posts  |  Last Activity: 1 hour 34 minutes ago Member since: Apr 18, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • freddyaophelps freddyaophelps Apr 28, 2016 9:14 PM Flag

    Counterfeiting Stock; An Eye Opening Article
    smithonstocks, posted by Larry Smith on JUN 16, 2015
    Excerpts:

    Illegal naked shorting and stock manipulation are two of Wall Street's deep, dark secrets. These practices have been around for decades and have resulted in trillions of dollars being fleeced from the American public by Wall Street. In the process, many emerging companies have been put out of business. The stocks most frequently targeted are those of emerging companies who went to the stock market to raise start–up capital.

    The identity of the shorts is somewhat elusive as the shorts obscure their true identity by hiding behind the prime brokers and/or hiding behind layers of offshore domiciled shell corporations. Frequently the money is laundered through banks in a number of tax haven countries before it finally reaches its ultimate beneficiary in New York, New Jersey, San Francisco, etc. Some of the hedge fund managers who are notorious shorters, such as David Rocker and Marc Cohodes, are very public about their shorting, although they frequently utilize offshore holding companies to avoid taxes and scrutiny.
    Most of the prime brokers have multiple offshore subsidiaries or captive companies that actively participate in shorting. The prime brokers also front the shorting of some pretty notorious investors. According to court documents or sworn testimony, if one follows one of the short money trails at Solomon, Smith Barney, it leads to an account owned by the Gambino crime family in New York. A similar exercise with other prime brokers, who cannot be named at this time, leads to the Russian mafia, the Cali drug cartel, other New York crime families and the Hell's Angels.
    One short hedge fund that was particularly destructive was a shell company domiciled in Bermuda. Subpoenas revealed the Bermuda company was wholly owned by another shell company that was domiciled in another tax haven country. This process was five layers deep, and at the end of the subterfuge was a very well known American insurance company that cannot be disclosed because of court–ordered sealing of testimony.
    Most of the large securities firms, insurance companies and multi–national companies have layers of offshore captives that avoid taxes, engage in activities that the company would not want to be publicly associated with, like stock manipulation; avoid U.S. regulatory and legal scrutiny; and become the closet for deals gone sour, like Enron.

  • Reply to

    Imetelstat =

    by freddyaophelps Apr 27, 2016 6:24 PM
    freddyaophelps freddyaophelps Apr 28, 2016 8:26 PM Flag

    NCI Drug Dictionary: Imetelstat sodium
    The sodium salt of imetelstat, a synthetic lipid-conjugated, 13-mer oligonucleotide N3' P5'-thio-phosphoramidate with potential antineoplastic activity. Complementary to the template region of telomerase RNA (hTR), imetelstat acts as a competitive enzyme inhibitor that binds and blocks the active site of the enzyme (a "telomerase template antagonist"), a mechanism of action which differs from that for the antisense oligonucleotide-mediated inhibition of telomerase activity through telomerase mRNA binding. Inhibition of telomerase activity in tumor cells by imetelstat results in telomere shortening, which leads to cell cycle arrest or apoptosis. Check for active clinical trials using this agent. (NCI Thesaurus)

  • On Wednesday the ICIJ said in an email that on May 9 it would "publish what will likely be the largest-ever release of information about secret offshore companies and the people behind them, based on data from the Panama Papers investigation. "The searchable database will include information about more than 200,000 companies, trusts, foundations, and funds incorporated in 21 tax havens, from Hong Kong to Nevada in the United States."

    Should be interesting when the Feds start comparing those records to asset disclosures, S-1 filings, tax records and tu sworn testimony in previous trials. Nervous times for the handlers of the paid postingchimps.

  • freddyaophelps freddyaophelps Apr 28, 2016 5:26 PM Flag

    There will be a huge new 'Panama Papers' data dump May 9th

    On Wednesday the ICIJ said in an email that on May 9 it would "publish what will likely be the largest-ever release of information about secret offshore companies and the people behind them, based on data from the Panama Papers investigation. "The searchable database will include information about more than 200,000 companies, trusts, foundations, and funds incorporated in 21 tax havens, from Hong Kong to Nevada in the United States."

    Rocko it will be interesting when the Feds start comparing those records to asset disclosures, S-1 filings, tax records and tu sworn testimony in previous trials. Nervous times for the handlers of the paid postingchimps.

  • Reply to

    Imetelstat =

    by freddyaophelps Apr 27, 2016 6:24 PM
    freddyaophelps freddyaophelps Apr 28, 2016 3:58 PM Flag

    "... and tiered royalties ranging from a double-digit up to a mid-teens percentage rate on worldwide net sales in any countries where regulatory exclusivity exists or there are valid claims under the patent rights exclusively licensed to Janssen"

    That could = a lot

  • freddyaophelps freddyaophelps Apr 28, 2016 3:51 PM Flag

    "The new raft of documents will be released on May 9, with basic corporate information on more than 200,000 offshore entities made available in a searchable database."

    Your bosses will care Larry.
    Smiley face for you.

  • freddyaophelps freddyaophelps Apr 28, 2016 12:34 PM Flag

    Bwaaahaha that's priceless! Profitable spammer Bwaaahaha!
    Very nice, bwaaahaha Exactly what I'm looking for bwaaahaha

    Thanks for playing chimp.
    Smiley face

  • freddyaophelps freddyaophelps Apr 28, 2016 11:50 AM Flag

    Re: Every year for five years.

    So you've been bashing this stock for five years but your alias is only one year old. Two questions... Why? and Why? Well let's make it 3 questions what other aliases have you bashed here under? Seems like a pathetic life little Larry.

  • freddyaophelps freddyaophelps Apr 28, 2016 11:41 AM Flag

    Then short it some more Larry, come back in a year and tell everyone how that worked for you.

    Thanks for being such a good sport chimp.
    Smiley face

  • freddyaophelps freddyaophelps Apr 28, 2016 11:35 AM Flag

    "we will receive a $65 million milestone payment at the time of the Continuation Decision plus a $70 million payment for Janssen's retention of full U.S. rights, and will be eligible to receive additional potential payments of up to $415 million in development and regulatory milestones, up to $350 million in sales milestones, and tiered royalties ranging from a double-digit up to a mid-teens percentage rate on worldwide net sales in any countries where regulatory exclusivity exists or there are valid claims under the patent rights exclusively licensed to Janssen"

    Thanks for being such a good sport Larry
    Smiley face

  • Reply to

    Imetelstat =

    by freddyaophelps Apr 27, 2016 6:24 PM
    freddyaophelps freddyaophelps Apr 28, 2016 11:30 AM Flag

    If we exercise the U.S. Opt-In Rights, then we and Janssen will share U.S. development and promotion costs on a 20/80 basis (Geron 20%, Janssen 80%), we will receive a $65 million milestone payment at the time of the Continuation Decision, and will be eligible to receive additional potential payments of up to $470 million in development and regulatory milestones, up to $350 million in sales milestones, and tiered royalties ranging from a mid-teens up to a low twenties percentage rate on worldwide net sales of imetelstat in any countries where regulatory exclusivity exists or there are valid claims under the patent rights exclusively licensed to Janssen. In addition, if we exercise the U.S. Opt-In Rights, we will also have a separate co-promotion option, or the U.S. Co-Promotion Option, to provide 20% of the U.S. selling effort with sales force personnel, in lieu of funding 20% of U.S. promotion costs, upon regulatory approval and commercial launch of imetelstat in the United States. Such co-promotion would be conducted under a Janssen prepared promotion plan, and in accordance with a co-promotion agreement to be agreed by us and Janssen at the time of our exercise of the U.S. Co-Promotion Option. We would be responsible for all costs associated with establishing and maintaining our sales force in any conduct of such co-promotion. All product sales would be booked by Janssen. If we do not exercise the U.S. Opt-In Rights upon an affirmative Continuation Decision by Janssen, then all further development and promotion costs beyond IMbark™ or IMerge™ will be borne by Janssen, we will receive a $65 million milestone payment at the time of the Continuation Decision plus a $70 million payment for Janssen's retention of full U.S. rights, and will be eligible to receive additional potential payments of up to $415 million in development and regulatory milestones, up to $350 million in sales milestones, and tiered royalties ranging from a double-digit up to a mid-teens percentage rate on worldwide net sales in any countries where regulatory exclusivity exists or there are valid claims under the patent rights exclusively licensed to Janssen.

  • freddyaophelps freddyaophelps Apr 27, 2016 11:57 PM Flag

    Not a threat Larry, just advice, you may want tu send this up the chain of command.

    " Anyone, located anywhere, who is potentially impacted by the public release of the Panama Papers should consider immediately contacting competent, experienced counsel"

    "U.S. individuals (citizens or legal residents) should contact competent tax counsel. The failure to declare certain interests in foreign financial accounts and assets can potentially bring about significant civil penalties and, in egregious situations, the possibility of criminal problems."

  • freddyaophelps freddyaophelps Apr 27, 2016 11:12 PM Flag

    Business Insider, UK
    By Lianna Brinded

    On Wednesday the ICIJ said in an email that on May 9 it would "publish what will likely be the largest-ever release of information about secret offshore companies and the people behind them, based on data from the Panama Papers investigation. "The searchable database will include information about more than 200,000 companies, trusts, foundations, and funds incorporated in 21 tax havens, from Hong Kong to Nevada in the United States."

    Be careful what you wish for papa beare, false S-1 filings will be easy tu prove.

  • ICIJ to Name Names in May
    " Anyone, located anywhere, who is potentially impacted by the public release of the Panama Papers should consider immediately contacting competent, experienced counsel"

    "U.S. individuals (citizens or legal residents) should contact competent tax counsel. The failure to declare certain interests in foreign financial accounts and assets can potentially bring about significant civil penalties and, in egregious situations, the possibility of criminal problems."

    "Waiting is simply not a viable option".

  • Reply to

    Imetelstat =

    by freddyaophelps Apr 27, 2016 6:24 PM
    freddyaophelps freddyaophelps Apr 27, 2016 10:29 PM Flag

    "it did something no other myelofibrosis therapy has ever done: induce a clinical response."

    Scary stuff for the 30 million share short and distort crew...

  • freddyaophelps freddyaophelps Apr 27, 2016 9:53 PM Flag

    "Imetelstat, in various early-stage clinical studies, actually produced partial and complete remission in select patients. If this data is replicable in larger studies and imetelstat proves safe, it could potentially become the leading myelofibrosis treatment."

  • freddyaophelps by freddyaophelps Apr 27, 2016 6:24 PM Flag

    "What makes Geron's imetelstat such an intriguing drug is that it did something no other myelofibrosis therapy has ever done: induce a clinical response. The only currently-approved FDA product works to minimize symptoms caused by the disease, including an enlarged spleen. Imetelstat, in various early-stage clinical studies, actually produced partial and complete remission in select patients. If this data is replicable in larger studies and imetelstat proves safe, it could potentially become the leading myelofibrosis treatment."

    Looked like poor spooge needed some help.
    Smiley face

  • Reply to

    Blackpuddin's motives

    by freddyaophelps Apr 26, 2016 2:31 PM
    freddyaophelps freddyaophelps Apr 27, 2016 1:59 PM Flag

    Re: Funny, most people learn from experience and don't make the same mistake twice.

    Oh Larry, I'm sure your familiar with John Rivera and John Stanton. You think they will show up in the May 9 Panama Papers tu?

  • freddyaophelps freddyaophelps Apr 27, 2016 1:36 PM Flag

    "There are some bad actors who pump stocks up and then dump them and this is every bit as egregious as naked shorting attacks. Interestingly, I believe that the hedge funds who short can be enthusiastic participants in these manipulation schemes as well."